Clinical Trial Update: Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating rivaroxaban for venous thromboembolism in cancer patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Venous Thromboembolism

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Venous Thromboembolism, Cancer | Phase 3 | Status: TERMINATED